The Refusal to File letter comes despite the FDA’s prior encouragement to submit a supplemental biologics license application ...

PE: What alternate strategies would have a better impact on reducing drug costs? Mendelsohn: Pushing for lower out-of-pocket ...

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...